Polypeptide

Polypeptide.ltd

Industry	Peptide
Founder(s)	Dr. Jean Zeng
Area served	Worldwide
Website	Polypeptide.ltd

Polypeptide.ltd., Polypeptide.ltd provides a full spectrum of high-quality peptide services ranging from Custom Peptide Synthesis (research and cGMP grade with Regular and Express deliveries) to high-throughput Peptide Library service. With access to the state-of-the-art equipment and experienced chemists using the latest technologies, we have delivered over 118,000 custom peptides to more than 3,300 scientists worldwide. Now, we have become the 1st vendor in peptide industry that can deliver peptides in as fast as 5 days at 100% guaranteed quantity to meet the ever-increasing peptide needs in biological and drug discovery research.

◐ Production capacity: Provide customization

◐ Large Factory Professional Manufacturers & Factory

◐ Production Carried OUT Under CGMP Regulation and Trackable

◐ ISO9001 & ISO14000

Products

• BPC-157

BPC 157 is a pentadecapeptide comprising 15 amino acids. It is derived from the body protection compound (BPC) found and isolated from human gastric juice. Animal studies have demonstrated its ability to expedite the healing process for various types of injuries, including muscle, tendon, and ligament damage. Moreover, BPC 157 has exhibited organ-protective properties and has been found to aid in the prevention of gastric ulcers. When administered systemically in the digestive tract, BPC-157 combats conditions such as leaky gut, IBS, gastrointestinal cramps, and Crohn’s disease. This peptide has also shown analgesic characteristics. Research has indicated that BPC-157 enhances the healing of skin burns by promoting increased blood flow to damaged tissues. Furthermore, it significantly accelerates the formation of reticulin and collagen, stimulates angiogenesis, and promotes the infiltration of macrophages and fibroblasts, making it a potential therapeutic tool for managing wound healing.

Production capacity: Provide customization

• CJC-1295 DAC

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to elevate plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). The addition of DAC (Drug Affinity Complex) to CJC-1295 extends its plasma half-life.

Production capacity: Provide customization

• GHRP-6

GHRP-6 is a potent stimulator of natural Growth Hormone Release from the anterior pituitary gland. It acts as an agonist of the ghrelin/growth hormone receptor and is among a few ghrelin analogues that have been developed in recent decades. One notable advantage of GHRP-6 is its oral and sublingual activity, allowing for convenient administration. Additionally, it demonstrates moderate to high selectivity for its target receptors.

Production capacity: Provide customization

• Gonadorelin

Gonadorelin, a gonadotropin-releasing hormone agonist, has demonstrated benefits in the treatment of infertility and hypogonadism. Recent research indicates its potential in slowing the growth of breast and prostate cancer. Additionally, studies have shown promising results in the treatment of Alzheimer’s disease.

Production capacity: Provide customization

• Ipamorelin

Ipamorelin is a pentapeptide, consisting of five amino acids, and functions as a growth hormone secretagogue. It acts as an agonist, binding to specific cell receptors and initiating a cellular response. By stimulating the pituitary gland, Ipamorelin promotes the secretion of growth-related substances in animal test subjects. Interestingly, it also inhibits the production of somatostatin, a specific secretion. Moreover, Ipamorelin has been observed to enhance the production of Insulin-like Growth Factor 1 (IGF-1), which is crucial for the growth and repair of muscular and skeletal tissues.

Production capacity: Provide customization

• Liraglutide

Liraglutide is a GLP-1 analogue, derived from a naturally occurring peptide that has the ability to lower blood sugar levels and enhance insulin secretion. Studies indicate that Liraglutide not only improves heart, liver, and lung function but also has potential benefits in slowing down or preventing the progression of Alzheimer’s disease. Additionally, Liraglutide has demonstrated significant appetite reduction by delaying gastric emptying and decreasing intestinal motility. To optimize its therapeutic properties, Liraglutide has been modified to have a longer half-life and more favorable pharmacokinetics.

Production capacity: Provide customization

• TB-500

Thymosin Beta-4 is a peptide consisting of 43 amino acids. In animal models, Thymosin Beta-4 has demonstrated the ability to enhance blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in both the heart and central nervous system. It plays a significant role in protecting, repairing, regenerating, and remodeling injured or damaged tissues. Additionally, Thymosin Beta-4 has garnered considerable attention in anti-aging research.

Production capacity: Provide customization

• Tirzepatide

Tirzepatide is a synthetic derivative that combines the functionalities of gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). This unique combination enables Tirzepatide to effectively lower blood glucose levels, improve insulin sensitivity, promote feelings of satiety, and facilitate weight loss. Initially developed as a treatment for type 2 diabetes, Tirzepatide has also demonstrated the ability to protect the cardiovascular system and act as a potent agent for weight loss.

Production capacity: Provide customization